www.roosterbio.com
Open in
urlscan Pro
67.207.94.90
Public Scan
Submitted URL: http://roosterbio.com/
Effective URL: https://www.roosterbio.com/
Submission: On November 30 via api from US — Scanned from DE
Effective URL: https://www.roosterbio.com/
Submission: On November 30 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://www.roosterbio.com/
<form class="search-form" method="get" action="https://www.roosterbio.com/" role="search">
<label>
<span class="screen-reader-text">Search For:</span>
<input type="search" class="search-field" placeholder="Search …" value="" name="s">
</label>
<button type="submit" class="search-submit"><span class="screen-reader-text">Search</span></button>
</form>
Text Content
Skip to content Menu SITE NAVIGATION * Our Technology * Foundation for Multiple Therapeutics * Powerful Technology * Built-In Manufacturing Process * Products * Human Mesenchymal Stem/Stromal Cells * Serum * Xeno-free * cGMP CliniControl™ * Cell Culture Media & Supplements * Serum * Xeno-free * cGMP CliniControl™ * Exosomes/Extracellular Vesicles * Media & Supplements * cGMP CliniControl™ Production Media * Genetic Engineering Tools * Genetic Engineering Media * Cell & Media Kits * hMSC Starter Kits * hMSC Donor Screening Kits * hMSC Tissue Screening Kits * Bioreactor Kits & Bundles * cGMP CliniControl™ Products * Human Mesenchymal Stem/Stromal Cells * Cell Culture Media & Supplements * Exosome/Extracellular Vesicle Production Media * Services * Process Development Services * hMSC Analytical Services * Exosome/Extracellular Vesicle Analytical Services * Knowledge Center * Resources * CoAs & QC Briefs * Publications * Videos & Webinars * Blog Articles * About Us * Why RoosterBio? * Our Leadership * Our Collaborators * Our Culture * Careers * FAQs * News & Events * News * Events * Press Releases * Media Kit * Contact Us * * * Search For: Search ACCELERATING HMSC & EXOSOME PRODUCT & PROCESS DEVELOPMENT TO FUEL THE RAPID IMPLEMENTATION OF SCALABLE ADVANCED THERAPIES * Cell Therapy * Gene Therapy * Exosomes * Tissue Engineering * Bioprocessing YOUR PATH TO THERAPEUTIC COMMERCIALIZATION At RoosterBio, we are experts in radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of therapeutic technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry leading quality, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to rapid acceleration in products coming to market that incorporate these technologies. RESEARCH & OPTIMIZATION High quality raw materials with built-in processes and protocols make it easy to establish MSCs in new programs. PRODUCT & PROCESS DEVELOPMENT Our complete hMSC systems offer robust and affordable solutions that allow you to focus on your final development goals. TECH TRANSFER & MANUFACTURING Seamlessly translate into the clinic with off-the-shelf cGMP products and processes that scale alongside you. OUR SCALABLE BIOPROCESSING SOLUTIONS No matter your scale, our hMSC and exosome systems with built-in processes significantly shorten development timelines and reduce costs on your journey to clinic and market. * 2D Standardized 2D (Flask) Bioprocess * 3D Standardized 3D (Bioreactor) Bioprocess * Exosomes Industrialized Exosome Production WEBINAR RECORDING EV ANALYTICS: KNOW YOUR PROCESS & DEFINE YOUR PRODUCT Size, heterogeneity, complex composition, and varying manufacturing processes make extracellular vesicles a challenge for conventional analytical tools. Watch Webinar PRODUCTS & SERVICES HIGH VOLUME HMSCS CELL CULTURE MEDIA & SUPPLEMENTS CGMP CLINICONTROL™ PRODUCTS EXOSOMES/EXTRACELLULAR VESICLES GENETIC ENGINEERING MEDIA DEVELOPMENT SERVICES WHY ROOSTERBIO? GLOBAL PRESENCE Supports over 200 government, academia, institution, and industry partners from more than 25 countries across 6 continents. REGULATORY EXPERTISE Our cGMP media and cells, supported by Type II FDA Master Files, are being used as ancillary and raw starting materials for multiple ongoing and planned registered clinical trials. THOUGHT LEADERSHIP Over 200 peer reviewed journal articles have cited RoosterBio's hMSCs and media since 2015. WHAT CUSTOMERS SAY Previous > One of the greatest advantages of using RoosterBio MSCs is that it enables us > to directly use hundreds of millions of cells for the fabrication of > densely-packed spheroids or cell-laden hydrogels at physiologically-relevant > cell densities. This is believed to have a huge impact on the fabrication of > scalable tissues with a great potential in replacing clinically relevant > tissue or organ loss. Ibrahim Ozbolat Professor, Penn State University > We’ve been very pleased with the performance of Rooster cells and media that > we’ve purchased - they’ve performed very well and consistently with > specifications. We’ve been particularly impressed with the quality of the > Rooster team - both their expertise and commitment to customer service. > They’ve gone the extra mile in helping us get up to speed with their products > and have been a pleasure to work with. Anonymous BioTech CEO > RoosterBio products have facilitated my research involving bone marrow-derived > MSCs by providing high-quality products that have been tested for purity and > performance. The robust MSC characterization practices followed by RoosterBio > is important for my lab’s research, and thus RoosterBio MSCs are our first > choice in commercial cell procurement. Rebekah Samsonraj Assistant Professor, University of Arkansas > Our CMC consultants recommended RoosterBio's platform as the industry's "gold > standard" in MSC manufacturing. We found the RoosterKit for growing human bone > marrow-derived MSCs straightforward and easy to use, with all the guesswork > taken out of the cell culture process. Anonymous BioTech Company > One of the greatest advantages of using RoosterBio MSCs is that it enables us > to directly use hundreds of millions of cells for the fabrication of > densely-packed spheroids or cell-laden hydrogels at physiologically-relevant > cell densities. This is believed to have a huge impact on the fabrication of > scalable tissues with a great potential in replacing clinically relevant > tissue or organ loss. Ibrahim Ozbolat Professor, Penn State University > We’ve been very pleased with the performance of Rooster cells and media that > we’ve purchased - they’ve performed very well and consistently with > specifications. We’ve been particularly impressed with the quality of the > Rooster team - both their expertise and commitment to customer service. > They’ve gone the extra mile in helping us get up to speed with their products > and have been a pleasure to work with. Anonymous BioTech CEO > RoosterBio products have facilitated my research involving bone marrow-derived > MSCs by providing high-quality products that have been tested for purity and > performance. The robust MSC characterization practices followed by RoosterBio > is important for my lab’s research, and thus RoosterBio MSCs are our first > choice in commercial cell procurement. Rebekah Samsonraj Assistant Professor, University of Arkansas > Our CMC consultants recommended RoosterBio's platform as the industry's "gold > standard" in MSC manufacturing. We found the RoosterKit for growing human bone > marrow-derived MSCs straightforward and easy to use, with all the guesswork > taken out of the cell culture process. Anonymous BioTech Company > One of the greatest advantages of using RoosterBio MSCs is that it enables us > to directly use hundreds of millions of cells for the fabrication of > densely-packed spheroids or cell-laden hydrogels at physiologically-relevant > cell densities. This is believed to have a huge impact on the fabrication of > scalable tissues with a great potential in replacing clinically relevant > tissue or organ loss. Ibrahim Ozbolat Professor, Penn State University Next EDUCATIONAL RESOURCES “WHERE DO WE COME FROM? WHAT ARE WE? WHERE ARE WE GOING?” KNOW YOUR PROCESS & DEFINE YOUR PRODUCT WITH EV/EXOSOME ANALYTICS November 15, 2022 Bioprocessing, Exosomes / Extracellular Vesicles LIFE AT THE ROOST – FROM NANO TO MACRO, “CROSS-TALK” SIGNALS BETWEEN MOLECULES, CELLS, & CAREER PATHS November 04, 2022 Corporate THE SUN NEVER SETS ON A WORLD SPINNING WITH HMSC ADVANCED THERAPEUTICS October 18, 2022 Cell Therapy View More Blog Articles FEATURED PUBLICATIONS TAILORING 2D FAST ITERATIVE FILTERING ALGORITHM FOR LOW-CONTRAST OPTICAL FRINGE PATTERN PREPROCESSING August 2022 Bioprocessing, MedTech, Devices, & Materials INTEGRATION OF IMAGING MODALITIES WITH LIPIDOMIC CHARACTERIZATION TO INVESTIGATE MSCS POTENCY METRICS May 2022 Bioprocessing, Cell Therapy, MedTech, Devices, & Materials UNDERSTANDING MESENCHYMAL STEM CELL IMMUNE POTENCY: A MORPHOLOMIC & LIPIDOMIC PERSPECTIVE May 2022 Bioprocessing, Cell Therapy, Immunomodulation View More Publications FEATURED WEBINAR ROOSTERGEM™: ADDRESSING KEY CHALLENGES IN EFFICIENT GENE TRANSFER TO PRIMARY CELLS Jun 2, 2021 Watch Webinar CONTACT INFORMATION 5295 Westview Drive, Suite 275 Frederick, MD 21703 Customer Service: +1 240-831-4914 Headquarters: +1 301-200-5366 Email: info@roosterbio.com SHARE * Twitter * Facebook * YouTube * LinkedIn Menu FOOTER NAVIGATION * Our Technology * Services * About Us * News & Events * Contact Us * Login * Products * Human Mesenchymal Stem/Stromal Cells * Cell Culture Media & Supplements * Exosomes/Extracellular Vesicles * Genetic Engineering Tools * Cell & Media Kits * cGMP CliniControl™ Products * Knowledge Center * Resources * Blog Articles * Publications * Videos & Webinars Copyright © 2022 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc. * Share on Facebook * Tweet * Share on LinkedIn * Email × We Value Your Privacy Settings NextRoll, Inc. ("NextRoll") and our advertising partners use cookies and similar technologies on this site and use personal data (e.g., your IP address). If you consent, the cookies, device identifiers, or other information can be stored or accessed on your device for the purposes described below. You can click "Allow All" or "Decline All" or click Settings above to customize your consent. NextRoll and our advertising partners process personal data to: ● Store and/or access information on a device; ● Create a personalized content profile; ● Select personalised content; ● Personalized ads, ad measurement and audience insights; ● Product development. For some of the purposes above, our advertising partners: ● Use precise geolocation data. Some of our partners rely on their legitimate business interests to process personal data. View our advertising partners if you wish to provide or deny consent for specific partners, review the purposes each partner believes they have a legitimate interest for, and object to such processing. If you select Decline All, you will still be able to view content on this site and you will still receive advertising, but the advertising will not be tailored for you. You may change your setting whenever you see the Manage consent preferences on this site. Decline All Allow All Manage consent preferences